You have 9 free searches left this month | for more free features.

lanreotide

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

Recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Lanreotide
  • New York, New York
  • +1 more
Oct 5, 2022

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Lanreotide
  • Y-90 microspheres
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

Terminated
  • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
  • lanreotide
  • Placebo
  • Bruxelles, Belgium
  • +23 more
Dec 21, 2022

Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)

Terminated
  • Acromegaly
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 12, 2022

Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

Recruiting
  • Metastatic Well Differentiated Neuroendocrine Neoplasm
  • Neuroendocrine Tumors
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)

Not yet recruiting
  • Neuroendocrine Tumors,Gastroenteropancreatic
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 9, 2021

Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)

Completed
  • Carcinoid Syndrome
  • Lanreotide
  • Placebo
  • Los Angeles, California
  • +53 more
Sep 15, 2022

Gastrointestinal Motility Disorder, Intestinal Disease Trial in New Hyde Park, New York (Lanreotide)

Completed
  • Gastrointestinal Motility Disorder
  • Intestinal Disease
  • Lanreotide
  • New Hyde Park, New York
  • +1 more
Dec 23, 2020

Acromegaly Trial in Santa Monica (lanreotide)

Terminated
  • Acromegaly
  • lanreotide
  • Santa Monica, California
    Brain Tumor Center and Pituitary Disorders Program, John Wayne C
Sep 2, 2021

Carcinoma, Hepatocellular, Neuroendocrine Tumors Trial in Aarhus (Sorafenib, Radiofrequency ablation (RFA) or surgery,

Completed
  • Carcinoma, Hepatocellular
  • Neuroendocrine Tumors
  • Aarhus, Aarhus C, Denmark
    Department of Hepatology and Gastroenterology
Apr 27, 2021

Small Intestinal NET, Carcinoid Heart Disease Trial (Telotristat Ethyl, Lanreotide)

Withdrawn
  • Small Intestinal NET
  • Carcinoid Heart Disease
  • Telotristat Ethyl
  • Lanreotide
  • (no location specified)
Jan 30, 2020

Autosomal Dominant Polycystic Kidney Disease (ADPKD Trial in Paris (Lanreotide, saline)

Completed
  • Autosomal Dominant Polycystic Kidney Disease (ADPKD
  • Paris, France
    Necker hospital
Nov 15, 2019

Neuroendocrine Tumors Trial in Seoul (Lanreotide)

Unknown status
  • Neuroendocrine Tumors
  • Lanreotide
  • Seoul, Korea, Republic of
    Youngsuk Park
May 17, 2019

Carcinoma, Merkel Cell Trial in Grenoble (Lanreotide)

Completed
  • Carcinoma, Merkel Cell
  • Lanreotide
  • Grenoble, France
    Grenoble University Hospital
Oct 17, 2017

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Netherlands (Lanreotide)

Unknown status
  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Lanreotide
  • Groningen, Netherlands
  • +3 more
May 19, 2017

Carcinoid Tumors Trial in Belgium, France (Lanreotide, Placebo (for sunitinib), Sunitinib)

Unknown status
  • Carcinoid Tumors
  • Lanreotide
  • +2 more
  • Brussels, Belgium
  • +19 more
Jan 30, 2017

Polycystic Livers (RESOLVE)

Completed
  • Polycystic Liver Disease
  • Lanreotide
  • Nijmegen, Gelderland, Netherlands
    Radboud University Hospital
Jul 8, 2014

Acid Reflux Esophagitis, Non-acid Reflux Esophagitis Trial in Jette (Lanreotide)

Unknown status
  • Acid Reflux Esophagitis
  • Non-acid Reflux Esophagitis
  • Lanreotide
  • Jette, Belgium
    University Hospital of Brussels
Jan 31, 2014

Polycystic Liver Disease, Hepatomegaly, Liver Diseases Trial in Leuven, Nijmegen (Placebo, Lanreotide)

Completed
  • Polycystic Liver Disease
  • +3 more
  • Placebo
  • Lanreotide
  • Leuven, Belgium
  • +1 more
Feb 16, 2009

Polycystic Liver Disease, Hepatomegaly, Liver Diseases Trial in Leuven, Nijmegen (lanreotide)

Unknown status
  • Polycystic Liver Disease
  • +4 more
  • lanreotide
  • Leuven, Belgium
  • +1 more
Nov 12, 2008